 |
 |
 |
 |
 |
|
 |
 |
|
 |
 |
|
 |
 |
 |
|
 |
Featured Article |
View More Featured Articles |
 |
 |
 |
Highlights from AAO: What's New in 2009 Neil J. Friedman, M.D. This year's meeting of the American Academy of Ophthalmology in San Francisco was well attended and the Moscone center was as busy as ever for the subspecialty days followed by the general sessions. Advances in techniques and technology and a variety of new products were discussed. more… |
| |
 |
 |
 |
 |
 |
|
 |
 |
News |
View More News |
 |
 |
Topcon Receives 510(k) Clearance for New Mydriatic/Non-Mydriatic Retinal Imaging System Paramus, NJ, September 24, 2009 – Topcon Medical Systems, Inc. has announced it has received FDA 510(k) clearance for the new TRC-NW7SF Mark II Digital Fundus Camera. Topcon will immediately more…
Study Finds Lack Of VEGF Can Cause Defects Similar To Dry Macular Degeneration Boston, MA—Scientists at Schepens Eye Research Institute have found that when the eye is missing a diffusible form of vascular endothelial growth factor (VEGF), i.e. one that when secreted can reach more…
Study Refutes Link Between Central Retinal Artery Occlusion And Neovascular Glaucoma Central retinal artery occlusion is not a direct cause of neovascular glaucoma, according to a more…
AAO: Photodynamic Therapy No Help In Treating Macular Degeneration Photodynamic therapy doesn't add to the effectiveness of standard treatment of wet age-related macular degeneration or decrease the need for intravitreal injections, according to findings of a more…
TBI-Vision Loss Impacts Vets; Low-Vision Patients May Have Hallucinations SAN FRANCISCO— Today's Scientific Program, 2009 American Academy of Ophthalmology (AAO) - Pan-American Association of Ophthalmology (PAAO) Joint Meeting, includes a Veterans Administration study that more…
|
 |
 |
 |
 |
 |
|
 |
 |
New Products |
View More New Products |
 |
 |
 |
3D OCT-2000 Spectral Domain OCT Topcon Medical Systems The Topcon 3D OCT-2000 System is the first Spectral Domain OCT system to incorporate a high resolution fundus camera and a user friendly color touch screen display in a compact, space saving design. The easy-to-use, intuitive FastMap™ software enables dynamic viewing of the OCT data, providing 3D, 2D and fundus images simultaneously. Pin-Point™ Registration properly indicates the location of the OCT image within the fundus image. In addition, the compare function allows users to view serial exams in a comparison view and apply different analytical tools. The seamless integration of the 3D OCT-2000 with Topcon's EyeRoute® Image Management System provides true connectivity and access to images anywhere, anytime. more… |
| |
 |
 |
 |
 |
 |
|
 |
 |
Featured Products |
|
 |
 |
Spectral OCT/SLO Combination Imaging System - OPKO Instrumentation more…
Eckardt 23 Gauge Cannula System - Dutch Ophthalmic, USA more…
OIS EyeScan - Ophthalmic Imaging Systems more…
Optiflex™ Surgical Assistant System - Volk Optical, Inc. more…
BD Visitec™ Vitreoretinal Brush [Grizzard] - BD Ophthalmics more…
|
 |
 |
 |
 |
 |
|
 |
 |
Events |
View More Events |
 |
 |
The 8th International Symposium on Ocular Pharmacology and Therapeutics December 3 - 6, 2009 Rome, Italy more…
|
 |
 |
 |
 |
 |
|
 |
 |
Journal Updates |
View More Journal Updates |
 |
 |
Vascular Events in Patients With Age-Related Macular Degeneration Treated With Intraocular Bevacizumab more…
The Neurovascular Retina in Retinopathy of Prematurity more…
Photodynamic Therapy and Intravitreal Triamcinolone for Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial more…
Intravitreal Bevacizumab for Choroidal Neovascularization Secondary To Presumed Ocular Histoplasmosis Syndrome more…
Changes in Aqueous Vascular Endothelial Growth Factor and Pigment Epithelium-derived Factor after Ranibizumab Alone or Combined with Verteporfin for Exudative Age-related Macular Degenerationa more…
|
 |
 |
 |
 |
 |
|
 |
 |
Technology Spotlight |
View More Technology Spotlights |
 |
 |
 |
Laser Photocoagulation Systems for Diabetic Retinopathy and Other Retinal Disorders The treatment of diabetic retinopathy has evolved dramatically over the past century. Before the advent of photocoagulation, surgeons had limited options available to treat retinal complications from diabetes. One approach that surgeons used on patients with proliferative retinopathy was to ablate their pituitary gland. This surgery was developed after Houssay et al. noted in 1930 that hypophysectomy reduced the severity of diabetes in pancreatectomized dogs. In the 1950s, pituitary ablation was attempted on humans using x-ray irradiation, surgical hypophysectomy, and yttrium-90 implantation. Patients treated in this manner demonstrated improvement in their diabetic retinopathy, but severe complications such as postural hypotension, sterility and death prevented its widespread use. more… |
| |
 |
 |
 |
 |
 |
|
 |
 |
^ top |
 |
 |
 |
 |
 |
|
 |